The Diagnosis of 18 F-fluorodexoxyglucose and 11C-Acetate PET/CT Scanning in Primary Liver Tumors and Tumor-Like Diseases : a Preliminary Study

HU Yu-xiao,ZHU Hang,LU Guang-ming,YANG Gui-fen,LI Quan-ying
DOI: https://doi.org/10.3969/j.issn.1006-9011.2012.03.025
2012-01-01
Journal of Medical Imaging
Abstract:Objective This preliminary study was designed to investigate the performance of positron emission tomography/ computer tomography(PET/CT) scanning for primary liver tumors and tumor-like diseases using 18F-fluorodexyoxyglucose(18F-FDG) and 11C-acetate(11C-ACT).Methods Nine patients(M:F=7:2,with mean age of 70.2),each of whom had one lesion only,were selected for this retrospective study.All patients had undergone a dual-tracer PET/CT scanning with 11C-ACT followed by 18F-FDG before treatment.The interval of two imaging was no more than one week.Verified by histopathology or clinical follow-up,there were 7 hepatocelluar carcinomas(HCCs),1 cholangiocarcinoma(CCC) and 1 infecting-lesion.Both PET/CT images were interpreted by two experienced nuclear physicians,based on visual assessment or semiquantitative analysis.Results 18F-FDG PET/CT showed equal or low uptake in 7 HCCs,and 11C-ACT PET/CT showed high uptake in 6 of them.Either 18F-FDG or 11C-ACT PET/CT scanning did not detect the well-differentiated CCC.The infecting-lesion showed high uptake in 18F-FDG PET/CT imaging,but equal in 11C-ACT PET/CT imaging.Conclusion ①11C-ACT PET/CT scanning would be used to detect HCCs,which showed equal or low uptake in 18F-FDG;②18F-FDG PET/CT scanning,might show a false-negative in detecting the well-differentiated CCC;③11C-ACT PET/CT scanning might be used to diagnose the infecting-lesions in liver.
What problem does this paper attempt to address?